Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator (Q37377433)

20 August 2017

1 reference

title

Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator (English)

1 reference

20 August 2017

Olivier van Beekum

1

1 reference

20 August 2017

Veerle Fleskens

series ordinal

2

1 reference

20 August 2017

Eric Kalkhoven

series ordinal

3

1 reference

20 August 2017

language of work or name

1 reference

1 February 2009

1 reference

20 August 2017

1 reference

20 August 2017

17

1 reference

20 August 2017

2

1 reference

20 August 2017

213-219

1 reference

The many faces of PPARgamma

20 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Controlling nuclear receptors: the circular logic of cofactor cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Lessons from human mutations in PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

PPAR-gamma regulates osteoclastogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

An adipogenic cofactor bound by the differentiation domain of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

The adipogenic acetyltransferase Tip60 targets activation function 1 of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Interdomain communication regulating ligand binding by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

The transcriptional complexity of the TFIIH complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Cellular control of gene expression by T-type cyclin/CDK9 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Control of peroxisome proliferator-activated receptor gamma2 stability and activity by SUMOylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Concepts in sumoylation: a decade on

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

A recurrent phospho-sumoyl switch in transcriptional repression and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

PDSM, a motif for phosphorylation-dependent SUMO modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Identification of SUMO-dependent chromatin-associated transcriptional repression components by a genome-wide RNAi screen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Mechanisms underlying ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

How the ubiquitin-proteasome system controls transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor gamma expression and adipogenesis in cultured 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Mapping protein post-translational modifications with mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Analysis of the Relationship between PPAR-γ 2 Gene Variants and Severe Insulin Resistance in Obese Patients with Impaired Glucose Tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

The Pro115Gln polymorphism within the PPAR gamma2 gene has no epidemiological impact on morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

ChIP-seq: welcome to the new frontier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

The age of crosstalk: phosphorylation, ubiquitination, and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Genome-wide approaches for identification of nuclear receptor target genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.473

31 March 2020

Identifiers

DOI

10.1038/OBY.2008.473

1 reference

20 August 2017

1 reference